Please use this identifier to cite or link to this item:
Title: EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): study protocol for a multicentre, observational trial
Authors: Weiss, Raphael
Saadat-Gilani, Khaschayar
Kerschke, Laura
Wempe, Carola
Meersch, Melanie
Zarbock, Alexander
Makhloufi, Hichem
Ghanem, Lamine Lakhel
Gouaglia, Zohier
Guadouri, Dina Nasrine
Rodríguez Pérez, Aurelio Eduardo 
UNESCO Clasification: 32 Ciencias médicas
3213 Cirugía
320506 Nefrología
3202 Epidemologia
Keywords: Acute renal failure
Adult intensive & critical care
Chronic renal failure
Issue Date: 2021
Journal: BMJ Open 
Abstract: Introduction: More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. Methods and analysis: EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. Ethics and dissemination: EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials.
ISSN: 2044-6055
DOI: 10.1136/bmjopen-2021-055705
Source: BMJ Open [ISSN 2044-6055] v. 11 (12), p. 055705 (Diciembre 2021).
Appears in Collections:Artículos
Adobe PDF (637,35 kB)
Show full item record


checked on May 23, 2024

Page view(s)

checked on Apr 29, 2023


checked on Apr 29, 2023

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.